DBVT News and Press, DBV Technologies S.A. From 02/06/20

Monthly information regarding the total number of voting rights and  total number of shares of the Company as of January 31, 2020 and February 4, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Pari...

Montrouge, France, February 6, 2020 DBV Technologies Announces Appointment of Pascal Wotling as Chief Technical Operations Officer DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the appointmen...

Aimmune Therapeutics (NASDAQ: AIMT) won approval from the U.S. Food and Drug Administration for its first drug -- and there are two more important firsts. Aimmune's Palforzia is the first approved drug to treat peanut allergies, and the first approved treatment for any kind of food allergy,...

Aimmune Gets a Boost as FDA Green Signals Allergy Medication Aimmune Therapeutics ( AIMT ) received FDA nod for its peanut allergy medication Palforzia. This orally administered medication aims to mitigate allergic reactions caused by exposure to peanuts. While it is not designed to be an ...

Gainers:  Datasea (NASDAQ: DTSS ) +81% . More news on: Datasea Inc., Sintx Technologies, Inc., ReTo Eco-Solutions, Inc., Stocks on the move, , Read more ...

Sundial Growers (NASDAQ: SNDL )  -26%  on CEO exit . More news on: Sundial Growers Inc., Briggs & Stratton Corporation, Intelsat S.A., , Stocks on the move, Read more ...

DVB Technologies (NASDAQ: DBVT ) slips  8%  premarket on light volume in reaction to its global offering of an aggregate of 7.5M ordinary shares via the following: More news on: DBV Technologies S.A., Healthcare stocks news, Stocks on the move, , Read more ...

Montrouge, France, January 30, 2020 DBV Technologies Announces Pricing of $153.7 million (€139.8 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares DBV Technologies (the “ Company ”) (Euronext: DBV – ISIN: FR001...

Montrouge, France, January 29, 2020 DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports December 31, 2019 Cash Position DBV Technologies (the “ Company ”) (Euronext: D...

UK-based Allergy Therapeutics ( OTCPK:AGYTF ) announces the publication of positive data on its peanut allergy vaccine candidate in The Journal of Allergy and Clinical Immunology. More news on: Allergy Therapeutics plc, Aimmune Therapeutics, Inc., DBV Technologies S.A., Healthcare sto...